Replies to post #139145 on Biotech Values

[DewDiligence]

BSX reports 1- and 2-year data for Promus Element:

http://finance.yahoo.com/news/landmark-analysis-two-data-platinum-165500292.html

The data look pretty good, but it will be tough for BSX to dislodge the market-leading Xience from its perch.

BSX no longer sells its regular Promus stent, which was an alias of Xience (#msg-69441708).